gemcitabine-dye conjugate

Gemcitabine-dye conjugates are experimental compounds in which the chemotherapeutic agent gemcitabine is covalently linked to a fluorescent dye, such as a cyanine dye. These constructs are designed as targeted theranostic agents for cancer therapy and imaging. The rationale is to combine the cytotoxic activity of gemcitabine—a nucleoside analog that inhibits DNA synthesis and induces apoptosis in tumor cells—with the tumor-targeting and imaging capabilities of near-infrared (NIR) dyes. The dye component enables real-time tracking of drug distribution and accumulation in tumors via fluorescence imaging, while the gemcitabine moiety retains its antitumor efficacy. Studies have shown that these conjugates can maintain or enhance cytotoxicity compared to free gemcitabine, with potential for improved selectivity and controlled release within tumor tissues[2][8]. Mechanistically, after cellular uptake—often facilitated by properties of both components—gemcitabine is released intracellularly where it undergoes phosphorylation to active metabolites that inhibit DNA synthesis[1][2].

Other names

gemcitabine–dye conjugatecyanine–gemcitabine conjugate